Cytokine patterns after tourniquet‐induced skeletal muscle ischaemia reperfusion in total knee replacement

References

• Ege T., Us M. H., Sungun M., Duran E. Cytokine response in lower extremity ischemia/reperfusion. J Int Med Res 2004; 32: 124–31
   Google Scholar
• Goris R. J. A. Local versus systemic inflammatory responses in shock, trauma and sepsis. Int J Intensive Care 1999; 6: 81–92
   Google Scholar
• Huda R., Solanki D. R., Mathru M. Inflammatory and redox responses to ischaemia/reperfusion in human skeletal muscle. Clin Sci (Lond) 2004; 107: 497–503
   Google Scholar
• Seekamp A., Jochum M., Ziegler M., van Griensven M., Martin M., Regel G. Cytokines and adhesion molecules in elective and accidental trauma‐related ischaemia/reperfusion. J Trauma 1998; 44: 874–82
   PubMed Web of Science ®Google Scholar
• Baumann H., Gauldie J. The acute phase response. Immunol Today 1994; 15: 74–80
   PubMedGoogle Scholar
• Baigrie R. J., Lamont P. M., Kwiatkowski D., Dallman M. J., Morris P. J. Systemic cytokine response after major surgery. Br J Surg 1992; 79: 757–60
   PubMed Web of Science ®Google Scholar
• Desborough J. P. The stress response to trauma and surgery. Br J Anaesth 2000; 85: 109–17
   PubMed Web of Science ®Google Scholar
• Hotchkiss R. S., Karl I. E. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138–50
   PubMed Web of Science ®Google Scholar
• Van Griensven M., Krettek C., Pape H. C. Immune reactions after trauma. 2003; 29: 181–92
   Google Scholar
• Bone R. C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24: 1125–8
   PubMed Web of Science ®Google Scholar
• Giannoudis P. V., Smith R. M., Perry S. L., Windsor A. J., Dickson R. A., Bellamy M. C. Immediate IL‐10 expression following major orthopaedic trauma: relationship to anti‐inflammatory response and subsequent development of sepsis. Intensive Care Med 2000; 26: 1076–81
   PubMed Web of Science ®Google Scholar
• Lyons A., Kelly J. L., Rodrick M. L., Mannick J. A., Lederer J. A. Major injury induces increased production of interleukin‐10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 1997; 226: 450–8
   PubMedGoogle Scholar
• Singer M., De Santis V., Vitale D., Jeffcoate W. Multiorgan failure is an adaptive, endocrine‐mediate, metabolic response to overwhelming systemic inflammation. Lancet 2004; 364: 545–8
   PubMed Web of Science ®Google Scholar
• Jarrar D., Chaudry I. H., Wang P. Organ dysfunction following haemorrhage and sepsis: mechanisms and therapeutic approaches. Int J Mol Med 1999; 4: 575–83
   PubMedGoogle Scholar
• Power C., Fanning N., Redmond H. P. Cellular apoptosis and organ injury in sepsis: a review. Shock 2002; 18: 197–211
   PubMed Web of Science ®Google Scholar
• Rensing H., Bauer M. Multiple organ failure. Mechanisms, clinical manifestation and therapeutical strategies. Anaesthetist 2001; 50: 819–41
   Google Scholar
• Talmor M., Hydo L., Barie P. S. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness. Arch Surg 1999; 134: 81–7
   PubMed Web of Science ®Google Scholar
• Cristofori L., Tavazzi B., Gambin R., et al. Early onset of lipid peroxidation after human traumatic brain injury: a fatal limitation for the free radical scavenger pharmacological therapy?. J Investig Med 2001; 49: 450–8
   Google Scholar
• Kong S. E., Blennerhassett L. R., Heel K. A., et al. Ischaemia–reperfusion injury to the intestine. Aust NZ J Surg 1998; 68: 554–61
   PubMedGoogle Scholar
• Gaines G. C., Welbom M. B 3de. Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumour necrosis factor. J Vasc Surg 1999; 29: 370–6
   PubMed Web of Science ®Google Scholar
• Seekamp A., Warren J. S., Remic D. G., Till G. O., Ward P. A. Requirements for tumour necrosis factor‐alpha and interleukin‐1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol 1993; 143: 453–63
   Google Scholar
• Germann G., Drucke D., Steinau H. U. Adhesion receptors and cytokine profiles in controlled tourniquet ischaemia in the upper extremity. J Hand Surg [Br] 1997; 22: 778–82
   Google Scholar
• Abraham E., Reinhart K., Opal S., et al. and OPTIMIST Trail Study Group. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. J Am Med Assoc 2003; 290: 238–47
   PubMed Web of Science ®Google Scholar
• Jyung R. W., Mustoe T. J. Clinical application and cytokines. Oxford University Press, New York 1993; 307–28
   Google Scholar
• Ayala A., Wang P., Ba Z. F., Perrin M. M., Ertel W., Chaudry I. H. Differential alterations in plasma IL‐6 and TNF levels after trauma and haemorrhage. Am J Physiol 1991; 260: 167–71
   PubMed Web of Science ®Google Scholar
• Roumen R. M., Hendriks T., van der Ven‐Jongekrijg J., Nieuwenhuijzen G. A., Sauerwein R. W., van der Meer J. W., et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993; 218: 769–76
   PubMed Web of Science ®Google Scholar
• Dahlback L. O., Rais O. Morphologic changes in striated muscle following ischemia. Acta Chir Scand 1966; 13: 430–40
   Google Scholar
• Patterson S., Klenermann Biwas M., Rhodes A. The effect of pneumatic tourniquet on skeletal muscle physiology. Acta Orthop Scand 1981; 52: 171–5
   PubMed Web of Science ®Google Scholar
• Damas P., Ledoux D., Nys M., Vrindts Y., De Groote D., Franchimont P., et al. Cytokine serum level during severe sepsis in human IL‐6 as a marker of severity. Ann Surg 1992; 215: 356–62
   PubMed Web of Science ®Google Scholar
• Blaisdell W. The pathophysiology of skeletal muscle ischemia and reperfusion syndrome. A review. Cardiovasc Surg 2002; 10: 620–30
   PubMedGoogle Scholar
• Cassidy N., Fitzgibbon M., Condron C., Moran R. Interleukin‐6 measurement. Regional variation in the trauma patient. Shock 1997; 7: 10
   Google Scholar
• Clementsen T., Krohn C. D., Reikeras O. Systemic and local cytokine patterns during total hip surgery. Scand J Clin Lab Invest 2006; 66: 535–42
   PubMed Web of Science ®Google Scholar
• Arnold J. P., Haeger M., Bengtson J. P., Bengtsson A., Lisander B. Release of inflammatory mediators in association with collection of wound drainage blood during orthopaedic surgery. Anaesth Intensive Care 1995; 23: 683–6
   PubMed Web of Science ®Google Scholar
• Krohn C. D., Reikeraas O., Mollnes T. E., Aasen A. O. Complement activation and release of interleukin‐6 and tumour necrosis factor‐alpha in drained and systemic blood after major orthopaedic surgery. Eur J Surg 1998; 164: 103–8
   PubMedGoogle Scholar
• van Deuren M., Twickler T. B., de Waal Malefyt M. C., van Beem H., van der Ven‐Jongekrijg J., Verschueren C. M. M. Elective orthopedic surgery, a model for the study of cytokine activation and regulation. Cytokine 1998; 10: 897–903
   PubMed Web of Science ®Google Scholar
• Hauser C. J., Joshi P., Zhou X., et al. Production of interleukin‐10 in human fracture soft‐tissue hematomas. Shock 1996; 6: 3–6
   PubMed Web of Science ®Google Scholar
• Woiciechowsky C., Schoning B., Lanksch W. R., et al. Mechanisms of brain‐mediated systemic anti‐inflammatory syndrome causing immunodepression [review]. J Mol Med 1999; 77: 769–80
   Google Scholar
• Rabinovici R., John R., Esser K., Vernick J., Feuerstein G. Serum tumor necrosis factor‐alpha profile in traumapatienta. J Trauma 1993; 35: 698–702
   PubMedGoogle Scholar
• Wakai P. Tourniquet induced systemic inflammatory response in extremity surgery. J Trauma, Injury, Infect Crit Care 2001; 11: 922–6
   Google Scholar
• Engelbarts I., Stephens S., Francot G. J. M. Evidence for different effects of soluble TNF‐[alpha] receptors on various TN measurements in human biological fluids. Lancet 1991; 2: 515–18
   Web of Science ®Google Scholar
• Tan L. R., Waxman K., Scannell G., et al. Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma 1993; 34: 634–47
   PubMedGoogle Scholar
• Härter L., Keel M., Hentze H., et al. Spontaneous in contrast to CD95‐induced neutrophil apoptosis is independent of caspase activity. J Trauma 2001; 50: 982–8
   Google Scholar
• Sternberg W. C., Tuttle T. M., Makhoul R. G., Bear H. D., Sobel M., Fowler A. A. Postischemic extremities exhibit immediate release of tumor necrosis factor. J Vasc Surg 1994; 20: 474–81
   Google Scholar
• Beutler B. A., Milsark I. W., Cerami A. Cachecetin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 1985; 135: 3972–7
   PubMed Web of Science ®Google Scholar
• Neidhardt R., Keel M., Steckholzer U., Safret A., Ungethuem U., Trentz O., et al. Relationship of interleukin‐10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997; 42: 863–71
   PubMedGoogle Scholar
• Smith R. M., Giannoudis P. V., Bellamy M. C., Perry B. S., Dickson R. A., Guillou P. J. Interleukin‐10 release and monocyte human leukocyte antigen‐DR expression during femoral nailing. Clin Orthop 2000; 373: 233–40
   Google Scholar
• Hensler T., Hecker H., Heeg K., Heidecke C. D., Bartels H., Barthlen W., et al. Distinct mechanism of immunosuppression as a consequence of major surgery. Infect Immunol 1997; 65: 2283–91
   PubMed Web of Science ®Google Scholar
• Brune I. B., Wilke W., Hensler T., Holzmann B., Siewert J. R. Downregulation of T helper type I immune response and altered pro‐inflammatory and antiinflammatory T‐cell cytokine balance following conventional but not laparoscopic surgery. Am J Surg 1999; 177: 55–60
   PubMed Web of Science ®Google Scholar